Author:
Sack Todd L.,Gum James R.,Kim Young S.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Sakahara H, Endo K, Nakashima T, Koizumi M, Ohta H, Hidaka A, Kohno S, Nakano Y, Naito A. Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma. Cancer 1986;57:1324–1326.
2. Loor R, Kuriyama M, Bodziak ML, Inaji H, Douglass HO Jr, Bergian R, Nicolai JJ, Tytgat GN, Chu M. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma. Cancer Res 1984;44:3604–3607.
3. Yuan S, Ho JLJ, Yuan M, Kim YS. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies. Cancer Res 1985;45:6179–6187.
4. Sawabu N, Toya D, Takemori Y, Hattori N, Fukui M. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. Int J Cancer 1986;37:693–696.
5. Podolsky DK. Serologic markers in the diagnosis and management of pancreatic carcinoma. World J Surg 1984;8:822–830.